Dissecting the genetic heterogeneity of gallbladder stone formation

Seminars in Liver Disease

Volumn 31, Issue 2, 2011, Pages 157-172

  Krawczyk, Marcin ^a   Wang, David Q H ^b   Portincasa, Piero ^c   Lammert, Frank ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF BARI   (Italy)

Author keywords

Candidate gene; cholelithiasis; genome wide association study; individualized medicine; multifactorial disease

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER G1; ANDROGEN RECEPTOR; ANKYRIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN C1; ATP BINDING CASSETTE TRANSPORTER B11; ATP BINDING CASSETTE TRANSPORTER B4; ATP BINDING CASSETTE TRANSPORTER G5; ATP BINDING CASSETTE TRANSPORTER G8; BETA 3 ADRENERGIC RECEPTOR; CALCINEURIN INHIBITOR; CEFTRIAXONE; CHOLECYSTOKININ A RECEPTOR; CHOLESTEROL; CHOLESTEROL 7ALPHA MONOOXYGENASE; CHOLESTEROL ESTER TRANSFER PROTEIN; CYANOCOBALAMIN; ESTROGEN RECEPTOR BETA; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUCOSE 6 PHOSPHATE ISOMERASE; GLUCURONOSYLTRANSFERASE 1A1; HEMOGLOBIN; INTERLEUKIN 8; OCTREOTIDE; ORGANIC ANION TRANSPORTER 2; PYRUVATE KINASE; TRANSCRIPTION FACTOR FKHR; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ARTICLE; BILE DUCT OBSTRUCTION; CHOLANGITIS; CHOLELITHIASIS; DUODENUM DIVERTICULUM; ENVIRONMENTAL FACTOR; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC RISK; HERITABILITY; HETEROZYGOTE; HUMAN; IMMOBILIZATION; INSULIN RESISTANCE; INTESTINE ABSORPTION; METABOLIC SYNDROME X; NONHUMAN; OBESITY; OVERNUTRITION; PANCREAS INSUFFICIENCY; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; SINGLE NUCLEOTIDE POLYMORPHISM; SPINAL CORD INJURY;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; GALLSTONES; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GLUCURONOSYLTRANSFERASE; HEREDITY; HUMANS; LIPOPROTEINS; PHENOTYPE; POLYMORPHISM, GENETIC; RISK ASSESSMENT; RISK FACTORS;

EID: 79955583628     PISSN: 02728087     EISSN: 10988971     Source Type: Journal    
DOI: 10.1055/s-0031-1276645     Document Type: Article

References (151)

1. Portincasa P, Moschetta A, Palasciano G. Cholesterol gallstone disease. Lancet 2006 368 9531 230-239 (Pubitemid 44037798)
2. Völzke H, Baumeister S E., Alte D et al. Independent risk factors for gallstone formation in a region with high cholelithiasis prevalence. Digestion 2005 71 2 97-105 (Pubitemid 40674577)
3. Palasciano G, Portincasa P, Vinciguerra V et al. Gallstone prevalence and gallbladder volume in children and adolescents: an epidemiological ultrasonographic survey and relationship to body mass index. Am J Gastroenterol 1989 84 11 1378-1382 (Pubitemid 19282059)
4. Lammert F, Sauerbruch T. Mechanisms of disease: the genetic epidemiology of gallbladder stones. Nat Clin Pract Gastroenterol Hepatol 2005 2 9 423-433 (Pubitemid 41486095)
5. Attili A F., Capocaccia R, Carulli N et al, Multicenter Italian Study on Epidemiology of Cholelithiasis. Factors associated with gallstone disease in the MICOL experience. Hepatology 1997 26 4 809-818 (Pubitemid 27413641)
6. Barbara L, Sama C, Morselli Labate A M. et al. A population study on the prevalence of gallstone disease: the Sirmione Study. Hepatology 1987 7 5 913-917 (Pubitemid 17139241)
7. Gibney E J. Asymptomatic gallstones. Br J Surg 1990 77 4 368-372 (Pubitemid 20119367)
8. Festi D, Sottili S, Colecchia A et al. Clinical manifestations of gallstone disease: evidence from the multicenter Italian study on cholelithiasis (MICOL). Hepatology 1999 30 4 839-846 (Pubitemid 29458268)
9. Lammert F, Neubrand M W., Bittner R et al, Deutschen Gesellschaft fr Verdauungs- und Stoffwechselkrankheiten Deutschen Gesellschaft fr Viszeralchirurgie zur Diagnostik und Behandlung von Gallensteinen German Society for Digestive and Metabolic Diseases and German Society for Surgery of the Alimentary Tract. S3-guidelines for diagnosis and treatment of gallstones. Z Gastroenterol 2007 45 9 971-1001
10. Tomida S, Abei M, Yamaguchi T et al. Long-term ursodeoxycholic acid therapy is associated with reduced risk of biliary pain and acute cholecystitis in patients with gallbladder stones: a cohort analysis. Hepatology 1999 30 1 6-13 (Pubitemid 29300562)
11. Friedman G D., Raviola C A., Fireman B. Prognosis of gallstones with mild or no symptoms: 25 years of follow-up in a health maintenance organization. J Clin Epidemiol 1989 42 2 127-136 (Pubitemid 19069803)
12. Thistle J L., Cleary P A., Lachin J M., Tyor M P., Hersh T. The natural history of cholelithiasis: the National Cooperative Gallstone Study. Ann Intern Med 1984 101 2 171-175 (Pubitemid 14098321)
13. Liver Disease Subcommittee of the Digestive Disease Interagency Coordinating Committee. Gallbladder and biliary disease. In: National Institutes of Health, ed. Action Plan for Liver Disease Research. Bethesda, MD National Institutes of Health 2004 145-150
14. Katsika D, Grjibovski A, Einarsson C, Lammert F, Lichtenstein P, Marschall H U. Genetic and environmental influences on symptomatic gallstone disease: a Swedish study of 43,141 twin pairs. Hepatology 2005 41 5 1138-1143 (Pubitemid 40593922)
15. Wittenburg H, Lammert F. Genetic predisposition to gallbladder stones. Semin Liver Dis 2007 27 1 109-121
16. Krawczyk M, Mllenbach R, Weber S N., Zimmer V, Lammert F. Genome-wide association studies and genetic risk assessment of liver diseases. Nat Rev Gastroenterol Hepatol 2010 7 12 669-681
17. Schafmayer C, Hartleb J, Tepel J et al. Predictors of gallstone composition in 1025 symptomatic gallstones from Northern Germany. BMC Gastroenterol 2006 6 36
18. Wang H H., Portincasa P, Afdhal N H., Wang D Q. Lith genes and genetic analysis of cholesterol gallstone formation. Gastroenterol Clin North Am 2010 39 2 185-207, vii-viii
19. Lammert F, Miquel J F. Gallstone disease: from genes to evidence-based therapy. J Hepatol 2008 48 Suppl 1 S124-S135
20. Small D M. Role of ABC transporters in secretion of cholesterol from liver into bile. Proc Natl Acad Sci U S A 2003 100 1 4-6 (Pubitemid 36078019)
21. Dixon P H., van Mil S W., Chambers J et al. Contribution of variant alleles of ABCB11 to susceptibility to intrahepatic cholestasis of pregnancy. Gut 2009 58 4 537-544
22. Rosmorduc O, Hermelin B, Boelle P Y., Parc R, Taboury J, Poupon R. ABCB4 gene mutation-associated cholelithiasis in adults. Gastroenterology 2003 125 2 452-459 (Pubitemid 36929427)
23. Krawczyk M, Ljohann D, Schirin-Sokhan R et al. A 1254: Serum phytosterols and cholesterol precursors levels indicate increased cholesterol output and biosynthesis as independent predictive risk factors of cholesterol gallstones. Hepatology 2010 52 Suppl 4 929A
24. Acalovschi M, Ciocan A, Mostean O et al. Are plasma lipid levels related to ABCG5/ABCG8 polymorphisms? A preliminary study in siblings with gallstones. Eur J Intern Med 2006 17 7 490-494 (Pubitemid 44708739)
25. Gylling H, Hallikainen M, Pihlajamki J et al. Polymorphisms in the ABCG5 and ABCG8 genes associated with cholesterol absorption and insulin sensitivity. J Lipid Res 2004 45 9 1660-1665 (Pubitemid 39296205)
26. Cahalane M J., Neubrand M W., Carey M C. Physical-chemical pathogenesis of pigment gallstones. Semin Liver Dis 1988 8 4 317-328 (Pubitemid 19045630)
27. Brink M A., Slors J F., Keulemans Y C. et al. Enterohepatic cycling of bilirubin: a putative mechanism for pigment gallstone formation in ileal Crohn's disease. Gastroenterology 1999 116 6 1420-1427 (Pubitemid 29258891)
28. Johnson A D., Kavousi M, Smith A V. et al. Genome-wide association meta-analysis for total serum bilirubin levels. Hum Mol Genet 2009 18 14 2700-2710
29. Buch S, Schafmayer C, Völzke H et al. Loci from a genome-wide analysis of bilirubin levels are associated with gallstone risk and composition. Gastroenterology 2010 139 6 1942-1951, e2
30. Lin J P., Schwaiger J P., Cupples L A. et al. Conditional linkage and genome-wide association studies identify UGT1A1 as a major gene for anti-atherogenic serum bilirubin levelsthe Framingham Heart Study. Atherosclerosis 2009 206 1 228-233
31. Sanna S, Busonero F, Maschio A et al. Common variants in the SLCO1B3 locus are associated with bilirubin levels and unconjugated hyperbilirubinemia. Hum Mol Genet 2009 18 14 2711-2718
32. Wang D Q., Afdhal N H. Gallstone disease. In: Feldman M Brandt L Friedman L eds. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. 9th ed. Philadelphia Elsevier Saunders 2010 1089-1120
33. Huang Y C., Zhang X W., Yang R X. Changes in cholelithiasis in Tianjin in the past 30 years. Chin Med J (Engl) 1984 97 2 133-135
34. Huang Z Q. Characteristic features of cholelithiasis in China. A nationwide survey of 11342 surgical cases 1983-1985. Zhonghua Wai Ke Za Zhi 1987 25 6 321-329, 380
35. Zhu X, Zhang S, Huang Z. The trend of the gallstone disease in China over the past decade. Zhonghua Wai Ke Za Zhi 1995 33 11 652-658
36. Nagase M, Tanimura H, Setoyama M, Hikasa Y. Present features of gallstones in Japan. A collective review of 2,144 cases. Am J Surg 1978 135 6 788-790 (Pubitemid 8377323)
37. Nakayama F, Miyake H. Changing state of gallstone disease in Japan. Composition of the stones and treatment of the condition. Am J Surg 1970 120 6 794-799
38. Leitzmann M F., Giovannucci E L., Rimm E B. et al. The relation of physical activity to risk for symptomatic gallstone disease in men. Ann Intern Med 1998 128 6 417-425 (Pubitemid 28128701)
39. Leitzmann M F., Rimm E B., Willett W C. et al. Recreational physical activity and the risk of cholecystectomy in women. N Engl J Med 1999 341 11 777-784 (Pubitemid 29420472)
40. Misciagna G, Centonze S, Leoci C et al. Diet, physical activity, and gallstonesa population-based, case-control study in southern Italy. Am J Clin Nutr 1999 69 1 120-126 (Pubitemid 29031261)
41. Tsai C J., Leitzmann M F., Willett W C., Giovannucci E L. Glycemic load, glycemic index, and carbohydrate intake in relation to risk of cholecystectomy in women. Gastroenterology 2005 129 1 105-112 (Pubitemid 41002047)
42. Tsai C J., Leitzmann M F., Willett W C., Giovannucci E L. Dietary carbohydrates and glycaemic load and the incidence of symptomatic gall stone disease in men. Gut 2005 54 6 823-828 (Pubitemid 40732101)
43. Walcher T, Haenle M M., Mason R A., Koenig W, Imhof A, Kratzer W, EMIL Study Group. The effect of alcohol, tobacco and caffeine consumption and vegetarian diet on gallstone prevalence. Eur J Gastroenterol Hepatol 2010 22 11 1345-1351
44. Wang D Q., Cohen D E., Carey M C. Biliary lipids and cholesterol gallstone disease. J Lipid Res 2009 50 Suppl S406-S411
45. Rhl C E., Everhart J E. Association of diabetes, serum insulin, and C-peptide with gallbladder disease. Hepatology 2000 31 2 299-303 (Pubitemid 30078591)
46. Stampfer M J., Maclure K M., Colditz G A., Manson J E., Willett W C. Risk of symptomatic gallstones in women with severe obesity. Am J Clin Nutr 1992 55 3 652-658
47. Portincasa P, Grattagliano I, Palmieri V O., Palasciano G. Current pharmacological treatment of nonalcoholic fatty liver. Curr Med Chem 2006 13 24 2889-2900 (Pubitemid 44509714)
48. Nervi F, Miquel J F., Alvarez M et al. Gallbladder disease is associated with insulin resistance in a high risk Hispanic population. J Hepatol 2006 45 2 299-305 (Pubitemid 44026566)
49. Loria P, Lonardo A, Lombardini S et al. Gallstone disease in non-alcoholic fatty liver: prevalence and associated factors. J Gastroenterol Hepatol 2005 20 8 1176-1184 (Pubitemid 41602559)
50. Biddinger S B., Haas J T., Yu B B. et al. Hepatic insulin resistance directly promotes formation of cholesterol gallstones. Nat Med 2008 14 7 778-782
51. Cirillo D J., Wallace R B., Rodabough R J. et al. Effect of estrogen therapy on gallbladder disease. JAMA 2005 293 3 330-339 (Pubitemid 40116088)
52. Körner G. ber die familire Hufung der Gallenblasenkrankheiten. Zeitschrift der menschlichen Vererbungs und Konstitutionslehre 1937 20 528-582
53. van der Linden W. Genetic factors in gallstone disease. Clin Gastroenterol 1973 2 603-614
54. Nakeeb A, Comuzzie A G., Martin L et al. Gallstones: genetics versus environment. Ann Surg 2002 235 6 842-849 (Pubitemid 34547303)
55. Duggirala R, Mitchell B D., Blangero J, Stern M P. Genetic determinants of variation in gallbladder disease in the Mexican-American population. Genet Epidemiol 1999 16 2 191-204 (Pubitemid 29070264)
56. Puppala S, Dodd G D., Fowler S et al. A genomewide search finds major susceptibility loci for gallbladder disease on chromosome 1 in Mexican Americans. Am J Hum Genet 2006 78 3 377-392 (Pubitemid 43291221)
57. Lammert F, Wang D Q., Hillebrandt S et al. Spontaneous cholecysto- and hepatolithiasis in Mdr2-/- mice: a model for low phospholipid-associated cholelithiasis. Hepatology 2004 39 1 117-128 (Pubitemid 38461474)
58. Davit-Spraul A, Gendrot C, Parfait B et al. A58: Sequence variations of ABCB4 gene in the french cohort of hereditary cholestasis and cholelithiasis. Hepatology 2010 52 Suppl 4 348A-349A
59. Nakken K E., Labori K J., Rdningen O K. et al. ABCB4 sequence variations in young adults with cholesterol gallstone disease. Liver Int 2009 29 5 743-747
60. Jansen P L., Strautnieks S S., Jacquemin E et al. Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis. Gastroenterology 1999 117 6 1370-1379
61. van Mil S W., van der Woerd W L., van der Brugge G et al. Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11. Gastroenterology 2004 127 2 379-384 (Pubitemid 39091885)
62. Pullinger C R., Eng C, Salen G et al. Human cholesterol 7alpha-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype. J Clin Invest 2002 110 1 109-117 (Pubitemid 34743471)
63. Miyake J H., Duong-Polk X T., Taylor J M. et al. Transgenic expression of cholesterol-7-alpha-hydroxylase prevents atherosclerosis in C57BL/6J mice. Arterioscler Thromb Vasc Biol 2002 22 1 121-126 (Pubitemid 34076242)
64. Lancellotti S, Zaffanello M, Di Leo E, Costa L, Lonardo A, Tarugi P. Pediatric gallstone disease in familial hypobetalipoproteinemia. J Hepatol 2005 43 1 188-191 (Pubitemid 40805292)
65. Schneider H, Snger P, Hanisch E. In vitro effects of cholecystokinin fragments on human gallbladders. Evidence for an altered CCK-receptor structure in a subgroup of patients with gallstones. J Hepatol 1997 26 5 1063-1068 (Pubitemid 27242596)
66. Miller L J., Holicky E L., Ulrich C D., Wieben E D. Abnormal processing of the human cholecystokinin receptor gene in association with gallstones and obesity. Gastroenterology 1995 109 4 1375-1380
67. Wang D Q., Schmitz F, Kopin A S., Carey M C. Targeted disruption of the murine cholecystokinin-1 receptor promotes intestinal cholesterol absorption and susceptibility to cholesterol cholelithiasis. J Clin Invest 2004 114 4 521-528 (Pubitemid 39572102)
68. Buch S, Schafmayer C, Völzke H et al. A genome-wide association scan identifies the hepatic cholesterol transporter ABCG8 as a susceptibility factor for human gallstone disease. Nat Genet 2007 39 8 995-999 (Pubitemid 47185186)
69. Grnhage F, Acalovschi M, Tirziu S et al. Increased gallstone risk in humans conferred by common variant of hepatic ATP-binding cassette transporter for cholesterol. Hepatology 2007 46 3 793-801 (Pubitemid 47436126)
70. Katsika D, Magnusson P, Krawczyk M et al. Gallstone disease in Swedish twins: risk is associated with ABCG8 D19H genotype. J Intern Med 2010 268 3 279-285
71. Kuo K K., Shin S J., Chen Z C., Yang Y H., Yang J F., Hsiao P J. Significant association of ABCG5 604Q and ABCG8 D19H polymorphisms with gallstone disease. Br J Surg 2008 95 8 1005-1011
72. Stender S, Frikke-Schmidt R, Nordestgaard B G., Tybjrg-Hansen A. Sterol transporter adenosine triphosphate-binding cassette transporter G8, gallstones, and biliary cancer in 62,000 individuals from the general population. Hepatology 2011 53 2 640-648
73. Siddapuram S P., Mahurkar S, Duvvuru N R. et al. Hepatic cholesterol transporter ABCG8 polymorphisms in gallstone disease in an Indian population. J Gastroenterol Hepatol 2010 25 6 1093-1098
74. Lyons M A., Wittenburg H. Cholesterol gallstone susceptibility loci: a mouse map, candidate gene evaluation, and guide to human LITH genes. Gastroenterology 2006 131 6 1943-1970 (Pubitemid 44958528)
75. Renner O, Harsch S, Schaeffeler E et al. A variant of the SLC10A2 gene encoding the apical sodium-dependent bile acid transporter is a risk factor for gallstone disease. PLoS ONE 2009 4 10 e7321
76. Tsezou A, Tzetis M, Giannatou E et al. Gilbert syndrome as a predisposing factor for cholelithiasis risk in the Greek adult population. Genet Test Mol Biomarkers 2009 13 1 143-146
77. Raijmakers M T., Jansen P L., Steegers E A., Peters W H. Association of human liver bilirubin UDP-glucuronyltransferase activity with a polymorphism in the promoter region of the UGT1A1 gene. J Hepatol 2000 33 3 348-351 (Pubitemid 30663370)
78. Duvaldestin P, Mahu J L., Metreau J M., Arondel J, Preaux A M., Berthelot P. Possible role of a defect in hepatic bilirubin glucuronidation in the initiation of cholesterol gallstones. Gut 1980 21 8 650-655 (Pubitemid 10020936)
79. Fevery J, Verwilghen R, Tan T G., De Groote J. Glucuronidation of bilirubin and the occurrence of pigment gallstones in patients with chronic haemolytic diseases. Eur J Clin Invest 1980 10 3 219-226 (Pubitemid 10039209)
80. Ostrow J D. Unconjugated bilirubin and cholesterol gallstone formation. Hepatology 1990 12 3 Pt 2 219S-224S
81. Strassburg C P. Hyperbilirubinemia syndromes (Gilbert-Meulengracht, Crigler-Najjar, Dubin-Johnson, and Rotor syndrome). Best Pract Res Clin Gastroenterol 2010 24 5 555-571
82. Angelico M, Gandin C, Canuzzi P et al. Gallstones in cystic fibrosis: a critical reappraisal. Hepatology 1991 14 5 768-775
83. Freudenberg F, Broderick A L., Yu B B., Leonard M R., Glickman J N., Carey M C. Pathophysiological basis of liver disease in cystic fibrosis employing a DeltaF508 mouse model. Am J Physiol Gastrointest Liver Physiol 2008 294 6 G1411-G1420
84. Freudenberg F, Leonard M R., Liu S A., Glickman J N., Carey M C. Pathophysiological preconditions promoting mixed black pigment plus cholesterol gallstones in a DeltaF508 mouse model of cystic fibrosis. Am J Physiol Gastrointest Liver Physiol 2010 299 1 G205-G214
85. Vasavda N, Menzel S, Kondaveeti S et al. The linear effects of alpha-thalassaemia, the UGT1A1 and HMOX1 polymorphisms on cholelithiasis in sickle cell disease. Br J Haematol 2007 138 2 263-270 (Pubitemid 46976326)
86. Wasmuth H E., Keppeler H, Herrmann U, Schirin-Sokhan R, Barker M, Lammert F. Coinheritance of Gilbert syndrome-associated UGT1A1 mutation increases gallstone risk in cystic fibrosis. Hepatology 2006 43 4 738-741
87. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol 2009 51 2 237-267
88. Rosmorduc O, Poupon R. Low phospholipid associated cholelithiasis: association with mutation in the MDR3/ABCB4 gene. Orphanet J Rare Dis 2007 2 29
89. Schwertner H A., Vtek L. Gilbert syndrome, UGT1A1*28 allele, and cardiovascular disease risk: possible protective effects and therapeutic applications of bilirubin. Atherosclerosis 2008 198 1 1-11
90. Park J H., Wacholder S, Gail M H. et al. Estimation of effect size distribution from genome-wide association studies and implications for future discoveries. Nat Genet 2010 42 7 570-575
91. de los Campos G, Gianola D, Allison D B. Predicting genetic predisposition in humans: the promise of whole-genome markers. Nat Rev Genet 2010 11 12 880-886
92. Bansal V, Libiger O, Torkamani A, Schork N J. Statistical analysis strategies for association studies involving rare variants. Nat Rev Genet 2010 11 11 773-785
93. Plomin R, Haworth C M., Davis O S. Common disorders are quantitative traits. Nat Rev Genet 2009 10 12 872-878
94. Paumgartner G, Greenberger N. Diseases of the gallbladder and bile ducts. In: Longo D Faucia eds. Harrison's Gastroenterology and Hepatology. 1st eds. New York, NY McGraw-Hill Professional 2010 439-457
95. Di Ciaula A, Wang D Q., Wang H H., Bonfrate L, Portincasa P. Targets for current pharmacologic therapy in cholesterol gallstone disease. Gastroenterol Clin North Am 2010 39 2 245-264
96. Shiffman M L., Sugerman H J., Kellum J M., Brewer W H., Moore E W. Gallstone formation after rapid weight loss: a prospective study in patients undergoing gastric bypass surgery for treatment of morbid obesity. Am J Gastroenterol 1991 86 8 1000-1005
97. Shiffman M L., Kaplan G D., Brinkman-Kaplan V, Vickers F F. Prophylaxis against gallstone formation with ursodeoxycholic acid in patients participating in a very-low-calorie diet program. Ann Intern Med 1995 122 12 899-905
98. Sugerman H J., Brewer W H., Shiffman M L. et al. A multicenter, placebo-controlled, randomized, double-blind, prospective trial of prophylactic ursodiol for the prevention of gallstone formation following gastric-bypass-induced rapid weight loss. Am J Surg 1995 169 1 91-96, discussion 96-97
99. Vtek L, Muchov L, Zelenka J, Zadinov M, Malina J. The effect of zinc salts on serum bilirubin levels in hyperbilirubinemic rats. J Pediatr Gastroenterol Nutr 2005 40 2 135-140 (Pubitemid 40269731)
100. Hafkamp A M., Nelisse-Haak R, Sinaasappel M, Oude Elferink R P., Verkade H J. Orlistat treatment of unconjugated hyperbilirubinemia in Crigler-Najjar disease: a randomized controlled trial. Pediatr Res 2007 62 6 725-730 (Pubitemid 350158814)
101. Hofmann A F., Zakko S F., Lira M et al. Novel biotransformation and physiological properties of norursodeoxycholic acid in humans. Hepatology 2005 42 6 1391-1398 (Pubitemid 43260042)
102. Broderick A L., Wittenburg H, Lyons M A., Stechell K DR, Hofmann A F., Carey M C. Cystic fibrosis transmembrane conductance regulator gene mutations cause black pigment gallstone formation: new insights from mouse models and implications for therapeutic interventions in cystic fibrosis. In: Adler G Fuchs M Stange E F. eds. Gallstone Pathogenesis and Treatment. Dordrecht, The Netherlands Kluwer Academic Publishers 2004 24-27
103. Venneman N G., Buskens E, Besselink M G. et al. Small gallstones are associated with increased risk of acute pancreatitis: potential benefits of prophylactic cholecystectomy? Am J Gastroenterol 2005 100 11 2540-2550
104. Fracchia M, Pellegrino S, Secreto P et al. Biliary lipid composition in cholesterol microlithiasis. Gut 2001 48 5 702-706 (Pubitemid 32378594)
105. Moschetta A, Bookout A L., Mangelsdorf D J. Prevention of cholesterol gallstone disease by FXR agonists in a mouse model. Nat Med 2004 10 12 1352-1358 (Pubitemid 40022717)
106. Wang H H., Portincasa P, Mendez-Sanchez N, Uribe M, Wang D Q. Effect of ezetimibe on the prevention and dissolution of cholesterol gallstones. Gastroenterology 2008 134 7 2101-2110 (Pubitemid 351790745)
107. Ziga S, Molina H, Azocar L et al. Ezetimibe prevents cholesterol gallstone formation in mice. Liver Int 2008 28 7 935-947 (Pubitemid 352044442)
108. Grnhage F, Lammert F. Gallstone disease. Pathogenesis of gallstones: A genetic perspective. Best Pract Res Clin Gastroenterol 2006 20 6 997-1015 (Pubitemid 44793723)
109. Rosmorduc O, Hermelin B, Poupon R. MDR3 gene defect in adults with symptomatic intrahepatic and gallbladder cholesterol cholelithiasis. Gastroenterology 2001 120 6 1459-1467 (Pubitemid 32322320)
110. Lucena J F., Herrero J I., Quiroga J et al. A multidrug resistance 3 gene mutation causing cholelithiasis, cholestasis of pregnancy, and adulthood biliary cirrhosis. Gastroenterology 2003 124 4 1037-1042 (Pubitemid 36389806)
111. Figge A, Lammert F, Paigen B et al. Hepatic overexpression of murine Abcb11 increases hepatobiliary lipid secretion and reduces hepatic steatosis. J Biol Chem 2004 279 4 2790-2799 (Pubitemid 38114269)
112. Henkel A, Wei Z, Cohen D E., Green R M. Mice overexpressing hepatic Abcb11 rapidly develop cholesterol gallstones. Mamm Genome 2005 16 12 903-908 (Pubitemid 41759832)
113. Yu L, Li-Hawkins J, Hammer R E. et al. Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol. J Clin Invest 2002 110 5 671-680 (Pubitemid 34988791)
114. Xu H L., Cheng J R., Andreotti G et al. Cholesterol metabolism gene polymorphisms and the risk of biliary tract cancers and stones: a population-based case-control study in Shanghai, China. Carcinogenesis 2011 32 1 58-62
115. Klass D M., Lauer N, Hay B, Kratzer W, Fuchs M, EMIL Study Group. Arg64 variant of the beta3-adrenergic receptor is associated with gallstone formation. Am J Gastroenterol 2007 102 11 2482-2487 (Pubitemid 47631768)
116. Dixit M, Choudhuri G, Saxena R, Mittal B. Association of apolipoprotein A1-C3 gene cluster polymorphisms with gallstone disease. Can J Gastroenterol 2007 21 9 569-575 (Pubitemid 350011440)
117. Yao Y G., Qiu X, Ma M K., Pu D S., Xiao L J. Apolipoprotein AI-CIII-AIV gene cluster polymorphisms in relation to cholesterol gallstone. J Dig Dis 2007 8 1 52-57 (Pubitemid 46189211)
118. Han T, Jiang Z, Suo G, Zhang S. Apolipoprotein B-100 gene Xba I polymorphism and cholesterol gallstone disease. Clin Genet 2000 57 4 304-308 (Pubitemid 30235047)
119. Jiang Z Y., Han T Q., Suo G J. et al. Polymorphisms at cholesterol 7alpha-hydroxylase, apolipoproteins B and E and low density lipoprotein receptor genes in patients with gallbladder stone disease. World J Gastroenterol 2004 10 10 1508-1512
120. Kurzawski M, Juzyszyn Z, Modrzejewski A et al. Apolipoprotein B (APOB) gene polymorphism in patients with gallbladder disease. Arch Med Res 2007 38 3 360-363 (Pubitemid 46366086)
121. Lancellotti S, Zaffanello M, Di Leo E, Costa L, Lonardo A, Tarugi P. Pediatric gallstone disease in familial hypobetalipoproteinemia. J Hepatol 2005 43 1 188-191 (Pubitemid 40805292)
122. Wang H H., Wang D Q. Reduced susceptibility to cholesterol gallstone formation in mice that do not produce apolipoprotein B48 in the intestine. Hepatology 2005 42 4 894-904 (Pubitemid 41401128)
123. Liu F L., Lu W B., Niu W X. XbaI polymorphisms of apolipoprotein B gene: another risk factor of gallstone formation after radical gastrectomy. World J Gastroenterol 2010 16 20 2549-2553
124. Dixit M, Choudhuri G, Mittal B. Association of APOE-C1 gene cluster polymorphisms with gallstone disease. Dig Liver Dis 2006 38 6 397-403 (Pubitemid 44356216)
125. Kitsiou-Tzeli S, Giannatou E, Spanos I et al. Steroid hormones polymorphisms and cholelithiasis in Greek population. Liver Int 2007 27 1 61-68 (Pubitemid 46139428)
126. Srivastava A, Pandey S N., Dixit M, Choudhuri G, Mittal B. Cholecystokinin receptor A gene polymorphism in gallstone disease and gallbladder cancer. J Gastroenterol Hepatol 2008 23 6 970-975 (Pubitemid 351806570)
127. Miyasaka K, Takata Y, Funakoshi A. Association of cholecystokinin A receptor gene polymorphism with cholelithiasis and the molecular mechanisms of this polymorphism. J Gastroenterol 2002 37 Suppl 14 102-106 (Pubitemid 35385939)
128. Juvonen T, Savolainen M J., Kairaluoma M I., Lajunen L H., Humphries S E., Kesniemi Y A. Polymorphisms at the apoB, apoA-I, and cholesteryl ester transfer protein gene loci in patients with gallbladder disease. J Lipid Res 1995 36 4 804-812
129. Kovacs P, Kress R, Rocha J et al. Variation of the gene encoding the nuclear bile salt receptor FXR and gallstone susceptibility in mice and humans. J Hepatol 2008 48 1 116-124 (Pubitemid 350191984)
130. Dixit M, Choudhuri G, Keshri L J., Mittal B. Association of low density lipoprotein receptor related protein-associated protein (LRPAP1) gene insertion/deletion polymorphism with gallstone disease. J Gastroenterol Hepatol 2006 21 5 847-849 (Pubitemid 43793282)
131. Srivastava A, Srivastava A, Srivastava N, Choudhuri G, Mittal B. Organic anion transporter 1B1 (SLCO1B1) polymorphism and gallstone formation: High incidence of Exon4 CA genotype in female patients in North India. Hepatol Res 2011 41 1 71-78
132. Tamary H, Aviner S, Freud E et al. High incidence of early cholelithiasis detected by ultrasonography in children and young adults with hereditary spherocytosis. J Pediatr Hematol Oncol 2003 25 12 952-954 (Pubitemid 37523354)
133. Trotman B W., Bernstein S E., Bove K E., Wirt G D. Studies on the pathogenesis of pigment gallstones in hemolytic anemia: description and characteristics of a mouse model. J Clin Invest 1980 65 6 1301-1308 (Pubitemid 10122371)
134. Schröter W, Eber S W., Bardosi A, Gahr M, Gabriel M, Sitzmann F C. Generalised glucosephosphate isomerase (GPI) deficiency causing haemolytic anaemia, neuromuscular symptoms and impairment of granulocytic function: a new syndrome due to a new stable GPI variant with diminished specific activity (GPI Homburg). Eur J Pediatr 1985 144 4 301-305 (Pubitemid 16194446)
135. Borgna-Pignatti C, Rigon F, Merlo L et al. Thalassemia minor, the Gilbert mutation, and the risk of gallstones. Haematologica 2003 88 10 1106-1109 (Pubitemid 37362541)
136. Walker T M., Hambleton I R., Serjeant G R. Gallstones in sickle cell disease: observations from The Jamaican Cohort study. J Pediatr 2000 136 1 80-85 (Pubitemid 30468562)
137. Hsu L, Diwan B, Ward J M., Noguchi C T. Pathology of Berkeley sickle-cell mice includes gallstones and priapism. Blood 2006 107 8 3414-3415
138. Au W Y., Cheung W C., Hu W H. et al. Hyperbilirubinemia and cholelithiasis in Chinese patients with hemoglobin H disease. Ann Hematol 2005 84 10 671-674 (Pubitemid 41554244)
139. Au W Y., Cheung W C., Chan G C., Ha S Y., Khong P L., Ma E S. Risk factors for hyperbilirubinemia and gallstones in Chinese patients with b thalassemia syndrome. Haematologica 2003 88 2 220-222 (Pubitemid 37101501)
140. Galanello R, Piras S, Barella S et al. Cholelithiasis and Gilbert's syndrome in homozygous beta-thalassaemia. Br J Haematol 2001 115 4 926-928 (Pubitemid 34042911)
141. del Giudice E M., Perrotta S, Nobili B, Specchia C, d'Urzo G, Iolascon A. Coinheritance of Gilbert syndrome increases the risk for developing gallstones in patients with hereditary spherocytosis. Blood 1999 94 7 2259-2262 (Pubitemid 29467673)
142. Haverfield E V., McKenzie C A., Forrester T et al. UGT1A1 variation and gallstone formation in sickle cell disease. Blood 2005 105 3 968-972 (Pubitemid 40170862)
143. Kitsiou-Tzeli S, Kanavakis E, Tzetis M, Kavazarakis E, Galla A, Tsezou A. Gilbert's syndrome as a predisposing factor for idiopathic cholelithiasis in children. Haematologica 2003 88 10 1193-1194 (Pubitemid 37362555)
144. Chaar V, Kclard L, Diara J P. et al. Association of UGT1A1 polymorphism with prevalence and age at onset of cholelithiasis in sickle cell anemia. Haematologica 2005 90 2 188-199
145. Premawardhena A, Fisher C A., Fathiu F et al. Genetic determinants of jaundice and gallstones in haemoglobin E beta thalassaemia. Lancet 2001 357 9272 1945-1946 (Pubitemid 32568338)
146. Fertrin K Y., Melo M B., Assis A M., Saad S T., Costa F F. UDP-glucuronosyltransferase 1 gene promoter polymorphism is associated with increased serum bilirubin levels and cholecystectomy in patients with sickle cell anemia. Clin Genet 2003 64 2 160-162 (Pubitemid 36944110)
147. Passon R G., Howard T A., Zimmerman S A., Schultz W H., Ware R E. Influence of bilirubin uridine diphosphate-glucuronosyltransferase 1A promoter polymorphisms on serum bilirubin levels and cholelithiasis in children with sickle cell anemia. J Pediatr Hematol Oncol 2001 23 7 448-451 (Pubitemid 33031774)
148. Chu C H., Yang A M., Kao J H., Liu C Y., Chang W H., Yang W S. Uridine diphosphate glucuronosyl transferase 1A1 promoter polymorphism is associated with choledocholithiasis in Taiwanese patients. J Gastroenterol Hepatol 2009 24 9 1559-1561
149. Park S K., Andreotti G, Sakoda L C. et al. Variants in hormone-related genes and the risk of biliary tract cancers and stones: a population-based study in China. Carcinogenesis 2009 30 4 606-614
150. Hsing A W., Sakoda L C., Rashid A et al. Variants in inflammation genes and the risk of biliary tract cancers and stones: a population-based study in China. Cancer Res 2008 68 15 6442-6452
151. Dixit M, Choudhuri G, Mittal B. Association of lipoprotein receptor, receptor-associated protein, and metabolizing enzyme gene polymorphisms with gallstone disease: A case-control study. Hepatol Res 2006 36 1 61-69 (Pubitemid 44309282)